Compositions for treating amyotrophic lateral sclerosis
AssigneePharnext
InventorsDANIEL COHEN, SERGUEI NABIROCHKIN, ILYA CHUMAKOV, RODOLPHE HAJJ
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.
Claims17
A method of treating amyotrophic lateral sclerosis (ALS) or a related disorder, comprising administering to a subject in need thereof acamprosate and baclofen, or salts, prodrugs, derivatives of any chemical purity, or sustained-release formulations thereof.
A composition comprising riluzole, or a salt, prodrug, derivative of any chemical purity, or sustained-release formulation thereof, in combination with baclofen, or a salt, prodrug, derivative of any chemical purity, or sustained-release formulation thereof, and in further combination with acamprosate, or a salt, prodrug, derivative of any chemical purity, or sustained-release formulation thereof.
A tablet comprising baclofen, acamprosate and riluzole for simultaneous administration.
A unit dosage package comprising unit doses of i) acamprosate and baclofen and ii) riluzole, suitable for combined, separate or sequential administration.
Dependencies are inferred from the claim text.